[go: up one dir, main page]

MX2017009752A - Adn huesped como biomarcador de la enfermedad de crohn. - Google Patents

Adn huesped como biomarcador de la enfermedad de crohn.

Info

Publication number
MX2017009752A
MX2017009752A MX2017009752A MX2017009752A MX2017009752A MX 2017009752 A MX2017009752 A MX 2017009752A MX 2017009752 A MX2017009752 A MX 2017009752A MX 2017009752 A MX2017009752 A MX 2017009752A MX 2017009752 A MX2017009752 A MX 2017009752A
Authority
MX
Mexico
Prior art keywords
subject
diagnosing
crohn
disease
relative abundance
Prior art date
Application number
MX2017009752A
Other languages
English (en)
Other versions
MX376501B (es
Inventor
Cervino Alessandra
Original Assignee
Enterome
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Enterome filed Critical Enterome
Publication of MX2017009752A publication Critical patent/MX2017009752A/es
Publication of MX376501B publication Critical patent/MX376501B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se refiere a un método in vitro para diagnosticar la enfermedad de Crohn en un sujeto que comprende: a) obtener una muestra biológica de dicho sujeto, b) analizar la abundancia relativa del ADN huésped en dicha muestra y, c) diagnosticar que dicho sujeto sufre de la enfermedad de Crohn si dicha abundancia relativa es mayor que un valor de referencia. La presente invención se refiere también a un método in vitro para diagnosticar el estado (estable o inestable) de la enfermedad de Crohn en un sujeto, que comprende las etapas de: a) obtener una muestra biológica de dicho sujeto, b) analizar la abundancia relativa del ADN huésped en dicha muestra y c) diagnosticar que dicho sujeto tiene una enfermedad de Crohn en un estado inestable si dicha abundancia relativa es mayor que otro valor de referencia.
MX2017009752A 2015-01-30 2016-01-29 Adn huésped como biomarcador de la enfermedad de crohn. MX376501B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP15305142 2015-01-30
PCT/EP2016/051989 WO2016120475A1 (en) 2015-01-30 2016-01-29 Host dna as a biomarker of crohn's disease

Publications (2)

Publication Number Publication Date
MX2017009752A true MX2017009752A (es) 2017-12-07
MX376501B MX376501B (es) 2025-03-07

Family

ID=52577797

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017009752A MX376501B (es) 2015-01-30 2016-01-29 Adn huésped como biomarcador de la enfermedad de crohn.

Country Status (12)

Country Link
US (2) US9873914B2 (es)
EP (1) EP3250710B1 (es)
JP (1) JP6585175B2 (es)
CN (1) CN107208159A (es)
AU (1) AU2016211113A1 (es)
BR (1) BR112017014978A2 (es)
CA (1) CA2973307A1 (es)
ES (1) ES2693973T3 (es)
IL (1) IL253327B (es)
MX (1) MX376501B (es)
PL (1) PL3250710T3 (es)
WO (1) WO2016120475A1 (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2693973T3 (es) * 2015-01-30 2018-12-17 Enterome ADN hospedador como un biomarcador de la enfermedad de Crohn
CA3058943C (en) 2017-04-03 2023-10-17 Gusto Global, Llc Rational design of microbial-based biotherapeutics
SG11202007686VA (en) 2018-02-12 2020-09-29 10X Genomics Inc Methods characterizing multiple analytes from individual cells or cell populations
CN108220286A (zh) * 2018-03-28 2018-06-29 上海锐翌生物科技有限公司 粪便宿主dna甲基化检测方法
CN114882944B (zh) * 2022-06-22 2024-09-20 深圳微伴医学检验实验室 基于Metagenome测序的肠道微生物样品宿主性别鉴定方法、装置及应用
EP4495262A1 (en) 2023-07-21 2025-01-22 Luxia Scientific Host dna as a biomarker of vaginal health

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6586177B1 (en) * 1999-09-08 2003-07-01 Exact Sciences Corporation Methods for disease detection
US20040259101A1 (en) * 2003-06-20 2004-12-23 Shuber Anthony P. Methods for disease screening
CN101238224A (zh) * 2005-06-06 2008-08-06 惠氏公司 炎性肠病的外周血单核细胞的表达谱
RU2313576C1 (ru) * 2006-05-29 2007-12-27 Ростовский-на-Дону научно-исследовательский противочумный институт Федеральной службы по надзору в сфере защиты прав потребителей и благополучия человека РЕКОМБИНАНТНАЯ ПЛАЗМИДА, ЭКСПРЕССИРУЮЩАЯ КЛОНИРОВАННЫЙ ГЕН Ace VIBRIO CHOLERAE И ШТАММ ESCHERICHIA COLI-ПРОДУЦЕНТ ACCESSORY CHOLERAE ENTEROTOXIN VIBRIO CHOLERAE
EP2097540A4 (en) * 2006-11-17 2010-09-01 Genizon Biosciences Inc GENETIC CARD OF HUMAN GENES ASSOCIATED WITH CROHN'S DISEASE
WO2009065551A1 (en) * 2007-11-20 2009-05-28 Roche Diagnostics Gmbh Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
EP2377883A1 (en) * 2010-04-15 2011-10-19 Universite d'Auvergne Clermont I Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease
GB201107466D0 (en) * 2011-05-05 2011-06-15 Loktionov Alexandre Device and method for non-invasive collection of colorectal mucocellular layer and disease detection
US20140186845A1 (en) * 2011-06-14 2014-07-03 Universite Paul Sabatier - Toulouse Iii Methods for determining the expression level of a gene of interest including correction of rt-qpcr data for genomic dna-derived signals
CN103911440B (zh) * 2014-03-13 2015-04-22 南京医科大学 一种与铂类化疗药物肝脏毒性相关的snp标志物及其应用
ES2693973T3 (es) * 2015-01-30 2018-12-17 Enterome ADN hospedador como un biomarcador de la enfermedad de Crohn

Also Published As

Publication number Publication date
IL253327B (en) 2020-06-30
BR112017014978A2 (pt) 2018-03-20
CN107208159A (zh) 2017-09-26
EP3250710B1 (en) 2018-08-22
AU2016211113A1 (en) 2017-09-07
IL253327A0 (en) 2017-09-28
PL3250710T3 (pl) 2019-02-28
EP3250710A1 (en) 2017-12-06
US20180251844A1 (en) 2018-09-06
CA2973307A1 (en) 2016-08-04
US20160258017A1 (en) 2016-09-08
WO2016120475A1 (en) 2016-08-04
US9873914B2 (en) 2018-01-23
JP2018504909A (ja) 2018-02-22
JP6585175B2 (ja) 2019-10-02
ES2693973T3 (es) 2018-12-17
US10793911B2 (en) 2020-10-06
MX376501B (es) 2025-03-07

Similar Documents

Publication Publication Date Title
MX2017009752A (es) Adn huesped como biomarcador de la enfermedad de crohn.
EP4524255A3 (en) Methods and compositions for nucleic acid analysis
BR112017017025A2 (pt) métodos e composições para analizar componentes celulares
EA201892489A1 (ru) Число мишеней для мультиплексной оптимизированной амплификации с несоответствиями (moma)
MX2015012437A (es) Esteroides neuroactivos, composiciones, y usos de los mismos.
EA201792389A1 (ru) Пцр в реальном времени для мультиплексной оптимизированной амплификации с несоответствиями (moma) и для оценки неклеточной днк
EA201991105A1 (ru) Методы оценки риска с использованием общей и специфической неклеточной днк
EP4219744A3 (en) Methods of preparing nucleic acids for sequencing
MX2016012043A (es) Metodo para extraer caracteristicas morfologicas de una muestra de material biologico.
WO2016015058A3 (en) Methods of determining tissues and/or cell types giving rise to cell-free dna, and methods of identifying a disease or disorder using same
EA201491833A1 (ru) Основанные на клетках перекрестные анализы и их применение
EA201891291A1 (ru) Мультиспецифические антитела
EP4343788A3 (en) Diagnostic methods
EP4282977C0 (en) ANALYSIS OF MULTIPLE SPATIALLY DIFFERENTIATED NUCLEIC ACIDS FROM ORGANIC SPECIMENS
BR112017004379A2 (pt) determinação de vivacidade em multi-estágio
EA201691607A1 (ru) Микроорганоиды и способы их получения и применения
BR112016017986A2 (pt) anticorpos isolados, ácido nucleico isolado, célula hospedeira, métodos de produção de um anticorpo, de tratamento do câncer, de tratamento de uma doença e de detecção de jagged1 humana em uma amostra biológica, imunoconjugado, formulação farmacêutica e uso do anticorpo
EA201891292A1 (ru) Мультиспецифические антитела
EP4556576A3 (en) Methods to diagnose and treat acute respiratory infections
MY187050A (en) Cancer cell-specific antibody, anticancer agent, and cancer testing method
EA201890747A1 (ru) Способы лечения воспалительных заболеваний
BR112017016897A2 (pt) cepas fúngicas e métodos de uso
EA201790769A1 (ru) Определение уровней гликозаминогликанов методом масс-спектрометрии
EA201790504A1 (ru) Монослой мононуклеарных клеток периферической крови или клеток костного мозга и его применение
EA201990730A1 (ru) Рнк-биомаркеры для наследственного ангионевротического отека

Legal Events

Date Code Title Description
FG Grant or registration